Determination of Inherent Dissolution Performance of Drug Substances
The dissolution behavior of novel active pharmaceutical ingredients (API) is a crucial parameter in drug formulation since it frequently affects the drug release. Generally, a distinction is made between surface-reaction- and diffusion-controlled drug release. Therefore, dissolution studies such as...
Main Authors: | Dominik Sleziona, Amelie Mattusch, Gerhard Schaldach, David R. Ely, Gabriele Sadowski, Markus Thommes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/2/146 |
Similar Items
-
The interplay of dissolution, solution crystallization and solid-state transformation of amorphous indomethacin in aqueous solution
by: Raj Schneider, et al.
Published: (2020-12-01) -
Development and validation of an intrinsic dissolution method for nimodipine polymorphs
by: Riekes Manoela, et al.
Published: (2014-05-01) -
Recrystallization of Commercial Carbamazepine Samples—A Strategy to Control Dissolution Variability
by: Felicia Flicker, et al.
Published: (2012-01-01) -
Determination of Intrinsic Drug Dissolution and Solute Effective Transport Rate during Laminar Fluid Flow at Different Velocities
by: Sara B. E. Andersson, et al.
Published: (2021-06-01) -
Analysis of Dissolution of Salicylamide from Carrageenan Based Hard-Shell Capsules: A Study of the Drug-Matrix Interaction
by: Muhammad Al Rizqi Dharma Fauzi, et al.
Published: (2020-11-01)